Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

First subjects dosed in study comparing nasal nalmefene with nasal naloxone

April 6, 2021

Primary safety endpoint met in phase Ib/II study of BXCL-501 to treat opioid withdrawal symptoms

April 1, 2021

Brain cell alcohol metabolism affects behavior, addiction

March 25, 2021

DemeRx receives approval for phase I/II study of ibogaine in the U.K.

March 11, 2021

FDA gives clearance to initiate clinical development of KP-879

Jan. 28, 2021

Neuron-specific delivery platform based on a chimeric toxin for botulism postexposure treatment

Jan. 26, 2021

New adenosine A2A receptor antagonists presented by AMMS

Jan. 13, 2021

Braeburn receives complete response letter for Brixadi in the U.S.

Dec. 3, 2020

Nirsum Laboratories presents prodrugs of opioid receptor antagonists

Dec. 1, 2020

BP-C2 mitigates radiation-induced gastrointestinal syndrome in mice

Oct. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...